The association between sclerostin and incident type 2 diabetes risk: a cohort study.

Oriana Hoi Yun YuB RichardsC BergerR G JosseW D LeslieD GoltzmanS M KaiserC S KovacsK S Davison

Published in: Clinical endocrinology (2017)

We observed an association between sclerostin levels with fasting insulin levels and HOMA-IR, but there was no clear association with type 2 diabetes risk. Further studies are needed to understand the role of sclerostin in type 2 diabetes.

Keyphrases

type diabetes
glycemic control
cardiovascular disease
insulin resistance
skeletal muscle
blood pressure
case control